The second half of the day was fast paced and full of information. Folks, these are rough notes. Hope they help…Again my random thoughts are in italics. Dr Eric Prystowsky led off the with the best clinical papers of 2011: He is a great speaker and hit upon a bunch of important topics. The good […]
Search: “apixaban”
We found 31 results for your search.
You may have heard that AF is a tough disease to understand. Questions far outnumber answers. What causes AF? Why do some not feel it at all, while others are incapacitated? What’s the best treatment? Drugs? Ablation? Surgery? No treatment? Should I take a blood thinner…and which one? Where should one go for the best […]
Here is the pdf version: 2011 AF and Stroke Talk (Norton) And the power point version: 2011 AF and Stroke Talk (Norton) Overview: —We will start with the accepted evidence base for warfarin. —Then move to dispel four myths about using blood-thinners in AF: Myth 1: Rhythm-control strategies prevent stroke. Myth 2: Running the INR […]
You can mark August 2011 as an amazing month for news in the treatment of atrial fibrillation (AF). In this post, I will attempt to share what I have learned about the two new blood-thinning drugs, apixaban and rivaroxaban–both Factor Xa inhibitors. (Disclaimer: this is not a book chapter, rather a blog post from a […]
Categories
Breaking news in AF treatment
Good Sunday morning friends. Yesterday brought the news of yet another important breakthrough in the treatment of AF. Apixaban, another non-warfarin blood-thinner, the third all told, was found to be both superior to warfarin in preventing strokes, associated with less bleeding and had no significant side effects. There’s a lot of data to digest. I’m […]
I recently came across a very important blog post on the use of the novel new blood-thinner, dabigatran (Pradaxa). Fellow Kentucky cardiologist, and frequent TheHeart.org contributor, Dr. Melissa Walton-Shirley wrote this very detailed case presentation involving a cantankerous non-compliant rural patient with AF (atrial fibrillation) that sustained a stroke while “taking†dabigatran. Dr. Walton-Shirley details […]
The unrelenting epidemic of inactivity and excessive eating wreaks havoc on more than just the heart and blood vessels. Lugging around extra weight also breaks down the joints and back. For evidence, look no further than the waiting room of any orthopedist; the people waiting for joint replacements look the same as those waiting to […]
It’s been awhile since I have written about the treatment of atrial fibrillation (AF). I would like to remedy this by sharing a few thoughts on three recent stories about AF: one involved a soon-to-be-approved blood-thinning drug; the second highlighted a potentially exciting new device for ablating AF, and the third story irresponsibly sensationalized the […]
The dabigatran party isn’t even cleaned-up yet, when another warfarin competitor has hit the press wires. As reported on Cardiobrief from a Bayer press release, Rivaroxaban (Xarelto) was as effective as warfarin in stroke prevention in patients’ with AF. A composite of major and minor bleeding events were also similar to warfarin. Rivaroxaban is a […]